Oligodendrogliomas
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma (NCT03027388) | National Cancer Institute (NCI) | 2019-01-09 |
| Everolimus With and Without Temozolomide in Adult Low Grade Glioma (NCT02023905) | University of California, San Francisco | 2014-03-19 |
| Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas (NCT02388659) | University of Texas Southwestern Medical Center | 2014-02-01 |
| Clinical Development of MR Spectroscopy and Imaging in Brain Cancers (NCT02731521) | University of Texas Southwestern Medical Center | 2014-01-01 |
| Treatment Strategy for Low-grade Gliomas (NCT00897377) | Sun Yat-sen University | 2007-12-01 |
| Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours (NCT00213876) | University Hospital, Strasbourg, France | 2004-02-01 |
Track Oligodendrogliomas automatically
Every clearance here is in the API, with alerts when new ones post.